OFIX
Orthofix Medical Inc.
NASDAQ · Healthcare · Medical - Devices · US
$9.59
+2.24%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$9.46
From 52W high−40.91%
Volume296086.00
Market cap$390.63M
P/E (TTM)—
P/S (TTM)0.5x
Div yield—
Key dataOct 19, 2026
Open
$9.46
From 52W high
−40.91%
Volume
296086.00
Market cap
$390.63M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
5.7x
P/E (TTM)
—
RSI (14)
53.4
MomentumView details →
1D Return
+2.24%
YTD Return
−37.20%
SummaryUpdated Jun 1, 2026
Orthofix Medical Inc. (NASDAQ:OFIX) is a medical device and biologics company founded in 1980 and headquartered in Lewisville, Texas. The company went public in 1992 and has evolved through strategic acquisitions, most notably its merger with SeaSpine in January 2023, which significantly expanded its spine product portfolio. Orthofix operates globally across the United States, Europe, and other international markets, focusing on orthopedic and spine medical solutions. The company has undergone significant transformation in recent years, including a name change from Orthofix International N.V. in 2018 and strategic portfolio optimization to focus on higher-growth, more profitable product lines.
Similar companies
Latest newsMore news →
Carlsmed, Inc. appointed Richard Heppenstall as Chief Financial Officer effective September 28, 2026, with a $500,000 base salary and equity awards valued at $1,400,000 each.19d agoJuniper Investment Company, LLC, a 10% owner and director of Orthofix Medical Inc., sold 310,000 Orthofix Medical common shares for approximately $2.73 million across September 18 and September 21, 2026.22d ago